Document is current
Any future updates will be listed below
-
Authors
Linares-Pineda, Teresa M.
Fragoso-Bargas, Nicolas
Picón, María José
Molina-Vega, Maria
Jenum, Anne Karen
Sletner, Line
Lee-Ødegård, Sindre
Opsahl, Julia O.
Moen, Gunn-Helen
Qvigstad, Elisabeth
Prasad, Rashmi B.
Birkeland, Kåre I.
Morcillo, Sonsoles
Sommer, Christine
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (FI19/00178, PI18/01175)
Helse Sør-Øst RHF (2019092)
Servicio Andaluz de Salud (PI-0283-2018, PI-0419-2019, RC-0008-2021)
Norges Forskningsråd (271555/F20, 325640)
Australian Research Council (DE220101226)
- License Information
-
More Information
Article History
Received: 14 December 2023
Accepted: 2 February 2024
First Online: 13 February 2024
Declarations
:
: The Norwegian Regional Committee for Medical Health Research Ethics South East approved the STORK-G study including genetic and epigenetic data (ref. number 2015/1035). And the EPIDG study was approved by the Institutional review board at the Hospital Universitario Virgen de la Victoria, Málaga. Written informed consent from all participants was obtained before any study-related procedure.
: All authors revised the manuscript critically and approver the final version.
: The authors declare there is no conflict of interest.
